" /> Zilucoplan - CISMeF





Preferred Label : Zilucoplan;

Obsolete resource : false;

NCIt synonyms : C5 Inhibitor RA101495; Complement C5 Inhibitor RA101495;

NCIt definition : A synthetic macrocyclic peptide inhibitor of the terminal complement protein C5, with potential anti-inflammatory and cell protective activities. Upon subcutaneous administration, complement zilucoplan binds to a unique site in terminal complement protein C5, which blocks C5 cleavage into C5a and C5b and prevents the C5b-dependent assembly of the membrane-attack complex (MAC). Zilucoplan also inhibits the interaction between C5b and C6, thereby further blocking MAC assembly. This prevents MAC-mediated lysis and destruction of red blood cells (RBCs) that occurs in complement-mediated diseases, such as paroxysmal nocturnal hemoglobinuria (PNH), generalized myasthenia gravis (gMG) and lupus nephritis (LN). C5, a complement pathway protein, is expressed at high levels by the liver.;

UNII : YG391PK0CC;

InChIKey : JDXCOXKBIGBZSK-PSNKNOTQSA-N;

CAS number : 1841136-73-9; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1841136-73-9 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : RA 101495; RA101495;

NCI Metathesaurus CUI : CL545343;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
21/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.